Business
PharmaCorp Announces Definitive Agreement to Acquire PharmaChoice Canada Bannered Pharmacy in Ontario
Purchase price of approximately $8.2 millionThe acquisition represents a continued expansion of PharmaCorp’s footprint in Ontario SASKATOON, Saskatchewan, May 25, 2026 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a Canadian pharmacy acquisition and ownership platform for pharmacist-led community pharmacy ownership, today announced that it has entered into a definitive share purchase agreement, dated May 22, 2026 (the “Agreement”) to acquire from an arm’
About this update from Pharmacorp Rx Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"Purchase price of approximately $8.2 million","length":44,"tagName":"p"}]},{"val":[{"type":"text","content":"The acquisition represents a continued expansion of PharmaCorp’s footprint in Ontario","length":85,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":129,"olType":false},{"type":"text","content":"SASKATOON, Saskatchewan, May 25, 2026 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a Canadian pharmacy acquisition and ownership platform for pharmacist-led community pharmacy ownership, today announced that it has entered into a definitive share purchase agreement, dated May 22, 2026 (the “Agreement”) to acquire from an arm’s length vendor group a 100% interest in a PharmaChoice Canada bannered pharmacy located in Morrisburg, Ontario (the “Acquisition”). The Acquisition continues the expansion of the Corporation’s geographical footprint and operating scale. Further to PharmaCorp’s acquisition pipeline update announced in its press release dated April 30, 2026, in which the Corporation disclosed having executed non-binding LOIs, dated February 23, 2026, February 27, 2026, March 3, 2026 and March 23, 2026, respectively, in respect of four additional pharmacy acquisitions (the “LOIs”), this Acquisition represents the first conversion of those LOIs into a definitive share purchase agreement.","length":1046,"tagName":"p"},{"type":"text","content":"Upon completion, the Acquisition is expected to increase PharmaCorp’s store count to 15, including the eight PharmaChoice Canada bannered pharmacies in Eastern Canada previously announced on April 30, 2026 (the “Eight Store Acquisitions”).","length":239,"tagName":"p"},{"type":"text","content":"Acquisition","length":11,"tagName":"p"},{"type":"text","content":"“This Acquisition reflects the continued execution of our disciplined acquisition strategy,” said Alan Simpson, Executive Chair of PharmaCorp. “Importantly, the transaction is consistent with our acquisition framework and demonstrates our ability to convert previously disclosed letters of intent into definitive agreements while maintaining capital allocation discipline and acquisition parameters. Maintaining disciplined acquisition multiples and thoughtful capital deployment remains central to our growth strategy.”","length":520,"tagName":"p"},{"type":...